Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks
- PMID: 35844964
- PMCID: PMC9270233
- DOI: 10.1016/j.bsheal.2022.06.003
Harmonizing the COVID-19 sample biobanks: Barriers and opportunities for standards, best practices and networks
Expression of concern in
-
Editorial note to previously published articles.Biosaf Health. 2023 Oct 27;5(6):372. doi: 10.1016/j.bsheal.2023.10.004. eCollection 2023 Dec. Biosaf Health. 2023. PMID: 40197764 Free PMC article. No abstract available.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the practice of infectious diseases biobanking, as well as existing challenges and opportunities. Thus, the future of infectious diseases biobanking in the post-pandemic era, shall not be an "entry-level version" of its counterpart in non-communicable diseases and large population cohorts, but incorporate the lessons learned. Biobanks constitute a critical research infrastructure supported by harmonized practices through the implementation of international standards, and perceived within the broader scope of healthcare's intersection with research. This perspective paper considers the barriers in biobanking and standardization of practices, as well as the emerging opportunities in the field.
Keywords: Biobank best practices; Biobank networks; Biobank standards; Biobanks; COVID-19.
© 2022 Chinese Medical Association Publishing House. Published by Elsevier BV.
References
-
- Medina P.B., Garcia D.L., Cheong I.H., Lin R.T.P., Kozlakidis Z. Construction and application of biobanks for infectious diseases: focus on SARS-CoV-2. Innov. Digital Health Diagnost. Biomarkers. 2022;2:40–47. doi: 10.36401/IDDB-21-06. - DOI
-
- Organization for Economic Co-operation and Development (OECD) OECD Publishing; Paris, France: 2006. Creation and governance of human genetic research databases. - DOI
Grants and funding
LinkOut - more resources
Full Text Sources
